NAUT FY 2025 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$339M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6M

Operating Income

-$67M

Net Income

-$59M

EPS (Diluted)

$-0.47

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$52M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$191M

Total Liabilities

$34M

Stockholders' Equity

$157M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6M	-$6M	-1.8%
Operating Income	-$67M	-$81M	+18.0%
Net Income	-$59M	-$71M	+16.6%